Formulation Development and Optimization of Herbo Synthetic Lipospheres Based on Solidified Reverse Micellar Solutions for Therapeutic Management of Diabetes Mellitus
Article Sidebar
Main Article Content
Abstract
The therapeutic efficacy of bioactives from Anogessius leiocarpus, a medicinal plant widely used in folkloric medicine in Nigeria in the management of diabetes mellitus (DM), can be improved using novel drug delivery systems. The objective of this study is to evaluate the antidiabetic potentials of Anogessius leiocarpus root bark extracts and lipospheres delivery system loaded with A. leiocarpus root-bark methanol extract compared with glibenclamide, a standard antidiabetic. The root bark was powdered and then extracted using methanol, 95% ethanol, and a combination of 95% ethanol and trona using a Soxhlet extractor. Preliminary antidiabetic properties of A. leiocarpus root-bark extracts were determined in alloxanized rats, and thereafter the optimized methanol extract was formulated into lipospheres containing 1, 2 and 3%w/w of the extract by high-shear homogenization using 10%w/w lipid matrix composed of 30% Phospholipon® 90H in 70% beeswax. Physicochemical properties, in vitro drug release in simulated intestinal fluid (SIF, pH=7.4) and simulated gastric fluid (SGF, pH=1.2) and anti-diabetic properties were determined. The phytochemical screening revealed the presence of saponins, alkaloids, glycosides, steroids, reducing sugars, flavonoids and tannins. Spherical particles with particle size range 135±1.58 - 195±2.24µm, which were stable over four weeks were obtained. Higher drug release in SIF (up to 100%) than SGF (<50%) and a mixed order release mechanism were obtained. The formulations caused significant (P<0.05) reduction in blood glucose level which was comparable with that obtained with glibenclamide. Lipospheres are a potentially safer and cheaper alternative therapeutics for DM given the numerous side effects associated with conventional glibenclamide.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24: 237 – 246.
Koda-kimble MA, Young YL, Allderdge BK, Corelli LR, Guglielmo JB, Kradjan WA, Williams BR. Applied therapeutics: The Clinical Use of Drugs. 9thedition, Lippincott Williams and Wilkins, 50.5-50.35, (2009).
Owens DR. New horizons—alternative routes for insulin therapy. Nat Rev Drug Discov. 2002;1: 529 – 40.
Evans M, Schumm-Draeger PM, Vora J, King AB. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obes Metab. 2011;13: 677–84.
Akhter DT, Nijhu RS. Diabetes mellitus: a journey of insulin. Int Curr Pharm J. 2012;1: 32–42.
Harris MI. Diabetes in America. National Institute of Health, National Institute of Diabetes, and Digestive and Kidney Diseases. NIH (95-1468) 2nd edition. New York, pp.631–659, (1995).
World Health Organization (WHO). General guidelines for methodologies on research and evaluation of traditional medicines. World Health Organization, Geneva, Switzerland, (2002).
Morishita M, Peppas NA. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today. 2006;11: 19–20.
Pamnani D. Reality check on oral insulin. Pharma Express. 2008;3: 16 – 31.
Pavlakis M, Khwaja K. Pancreas and islet cell transplantation in diabetes. Curr Opin Endocrinol Diabetes Obes. 2007;14: 146.
Momoh MA, Kenechukwu FC, Nnamani PO, Umetiti JC. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres. Drug Deliv. 2015;22(6): 837 – 848.
Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New Engl J Med. 2007;356: 2457 – 2471.
Ajali U, Okoye FBC. Antimicrobial and anti-inflammatory activities of Olax viridis root bark extracts and fractions. Int J Applied Res Nat Prod. 2009;2(1): 27–32.
Dahanuka SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants and natural products. Indian J Pharmacol. 2002;2: 508–512.
Iwu MW, Duncan AR, Okunji CO. New antimalarials of plant origin. In: Janick J, ed. Perspective on new crops and new uses. Alexandria, VA: ASHS Press, pp.457–462, (1999).
Robbers J, Speedie M, Tyler V. Pharmacognosy and pharmacobiotechnology. Baltimore:Williams and Wilkins. pp.1–4, (1996).
Venkidesh R, Dilipkumar P, Ashok KCK, Saravanakumar A, Subhash C. Studies on antidiabetic potential of Symplocos racemosarox bark extract in streptozotocin induced diabetic rats. Int J Phytopharmac Res. 2012;3(1): 1 – 5.
Patiel A, Nirmal S, Pattan S, Tambe V, Tare M. Antidiabetic effect of polyherbal combinations in streptozotocin-induced diabetes involve inhibition of α-amylase and α-glucosidase with amelioration of lipid profile. Phytopharmacol. 2012;2(1): 46 – 57.
Kumudhavalli MV, Jaykar B. Evaluation of antidiabetic activity of Costus igneus leaves on streptozotocin induced diabetic rats. Der Pharmacia Sinica. 2012;3 (1): 1-4.
Nina A, Taufik F, Akhmad D. Bioactivities evaluation of indonesian mistletoes (Dendrophthoe pentandra (L.) Miq.) leaves extracts. J Appl Pharm Sci. 2012;2(1): 24–27.
Mizanur SK, Islam R, Rahman S, Mosaiah T, Rasheda A, Khatun T, Dilruba N, Nahar N, Ahsan S, Rahmatullah M. Antihyperglycemic studies with methanol extract of Annon areticulate L. (Annonaceae) and Carissa carandas L. (Apo cynaceae) leaves in swiss albino mice. Adv Nat Appl Sci. 2011;5(2): 218 – 222.
Lanjhiyana S, Garabadu D, Ahirwar D, Bigoniya P, Rana AC, Patra CK, Lanjhiyana S K, Karuppaih M. Antidiabetic activity of methanolic extract of stem bark of Elaeodendron glaucum in alloxanized rat model. Adv Appl Sci Res. 2011;2(1): 47-62.
Priya RM, Krishna SM, Padmakumari KP, Raghu GK, Sundaresan A. Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: an in vitro study. J Sci Food Agric. Abstract, 2012;10.1002.
Momoh MA, Chime SA, Kenechukwu FC. Novel drug delivery system of plant extract for the management of diabetes: An antidiabetic study. J Diet Suppl. 2013;1-12. DOI:10.3109/19390211.2013.822454.
Mann A, Barnabas BB, Daniel II. Phytochemical and antibacterial screening of Anogessius leiocarpus against some microorganisms assiociated with infectious wounds. Afri J Microbiol Res. 2008;2: 60 – 62.
Ibrahim MB, Owonubi MO, Onaopo JA. Antibacterial effect of extract leaf, stem and root bark of Anogessius leiocarpus on some bacterial organism. J Pharm Res Dev. 1997;2(1): 20-23.
Saraf AS. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81: 680 – 689.
Esposita ER, Cortesi SJ, Nastruzzi C. Production of lipospheres for bioactive compound delivery. In: Claudio N, ed. Lipospheres in drug targets and delivery: Approaches, methods and applications. Florida: CRC press, pp.23-40, (2007).
Domb AJ, Bergelson L, Amselem S. Lipospheres for controlled delivery of substances. In: Benita S, ed. Microencapsulation: Methods and industrial applications. New York: Marcel Dekker, p.377, (1996).
Bekerman T, Golenser J, Domb A. Cyclosporin nanoparticulate lipospheres for oral administration. J Pharm Sci. 2004;93: 1264–1270.
Domb A. Lipospheres for controlled delivery of substances. In: Benita S, ed. Microencapsulation: Methods and industrial applications. 2nd ed. Boca Raton: Taylor and Francis, pp.297–316, (2006).
Mangenheim B, Levy MY, Benita S. An in vitro technique for evaluation of drug release profile from colloidal carriers – ultrafiltration technique at low pressure. Int J Pharm. 1993;94: 115 – 120.
Singh RM, Singh D, Swarnlata S. Development and in vitro evaluation of polar lipid based lipospheres for oral delivery of peptide drugs. Int J Drug Deliv. 2009;1: 15 – 26.
Domb AJ, Maniar AB, Manoj MD. Liposphere for controlled delivery of substances. European Patent. EP0502119, (1996).
Chime SA, Kenechukwu FC, Onunkwo GC, Attama AA, Ogbonna JDN. Recent advances in lipospheres drug delivery system. J Pharm Res. 2012;5(3): 1743 – 1748.
Attama AA, Okafor CE, Builders PF, Okorie O. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium Drug Deliv. 2009;16: 448 – 616.
Kenechukwu FC, Momoh MA, Nnamani PO, Ogbonna JDN, Umeyor CE, Attama AA. Improved bioactivity of gentamicin from novel solid lipid microparticles based on beeswax. Nig J Pharm Res. 2014;10(1): 35-45.
Attama AA, Muller-Goymann CC. Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf A: Physicochem Eng Aspects. 2008;315: 189-195.
Porter JH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6: 231 – 48.
Phospholipid. Phospholipon® 90H. Phospholipid GmbH, Nattermannallee, American lecithin company, (2007).
Hitesh RP, Rakesh PP, Patel MM. Poloxamers: A pharmaceutical excipient with therapeutic behaviors. Int J PharmTech Res. 2009;2: 299 - 303.
Barbosa CMS, Morais HA, Deivivo FM, Mansur HS, Oliveira MCD, Silvestre MPC. Papain hydrolysates of casein: Molecular weight profile and encapsulation in lipospheres. J Sci Food Agric. 2004;84: 1891 – 1900.
Trease GE, Evans MC. Textbook of Pharmacognosy. 12th edition, London: BailliereTindall, London. pp.343 – 383, (1983).
Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1983;54: 275 – 287.
Chime SA, Onyishi IV, Attama AA, Onunkwo GC, Ajaraonye MC. Lipospheres: A potential delivery system of herbal extract for the treatment of diabetes mellitus. Am J PharmTech Res. 2013;3(4): 479 – 491.
Lambia SS, Buch KY, Lewis JR. Phytochemicals as potential hypoglycemic agents. Studies Nat Prod Chem. 2000;21: 457 – 479.
Goutam B. Bio-flavonoids with promising antidiabetic potentials: A critical survey. Opportunity, challenge and scope. Nat Prod Chem. ISBN: 978-81-308-0448-4, pp.187-212, (2011).
Kanti BP, Syed IR. Plant polyphenol as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5): 270 – 278.
Matsuda H, Yuhao LI, Murakami T, Matsumura N, Yamahara J, Yoshikawa M. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem Pharm Bull. 1998;1399-1403.
ZurMuhlen A, Scwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery: drug release and release mechanism. Eur J Pharm Biopharm. 1998;45: 149 – 155.
Kenechukwu FC, Attama AA, Ibezim EC, Nnamani PO, Umeyor CE, Uronnachi EM, Gugu TH, Momoh MA, Ofokansi KC, Akpa PA. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis. Eur J Pharm Sci. 2018;111: 358 – 375.
Ram CD. Variables affecting the drug entrapment efficiency of microspheres: A pharmaceutical review. Pharmacia Letter. 2010;2(5): 102-116.
Singh MN. Microencapsulation: A promising technique for controlled drug delivery. Res Pharm Sci. 2010;5(2): 65 – 77.
Hauss DS. Oral lipid-based formulations. Adv Drug Del Rev. 2009;57: 667 – 76.
Guruswami S, Kumar V, Mishra DN. Characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Chem Pharm Bull. 2006;54: 1102–6.